As Poslovni Dnevnik writes, revenues from the Croatian company Podravka’s sales for the first nine months of this year amounted to a very impressive 1,651.4 million kuna, which is 3.9 percent more than what was recorded back during the same period last year. Since last year, due to the poor epidemiological situation, there was an increase in demand for Podravka’s products and the creation of increased stocks with customers across almost all markets, making this year’s growth is even more significant.
If, for example, we compare the Croatian company Podravka’s revenues with the pre-pandemic year of 2019, then revenue growth this year is even more significant, standing at 5.4 percent.
Sales revenue growth this year was achieved in almost all business programmes, among which the most significant growth of 5.2 percent was recorded in the Culinary business programme. The aforementioned growth in this particular segment was achieved mainly due to the growth of revenues from the sale of Universal Food Additives and Soups.
When it comes to sales revenue by region, growth was achieved across all of this company’s key markets. Particular emphasis is placed on revenue growth of 9.5 percent in the Western Europe region, where growth was achieved in almost all business programmes, of which the largest growth was generated by the Culinary, Podravka food and Baby food segments.
It is worth noting that the other two most significant regions also achieved sales revenue growth, of which in Central Europe there was a growth of 4.4 percent, while the Adria region achieved sales revenue growth of 2.9 percent.
When we look at the business results of the Podravka Group for the first nine months of this year, an impressive 3,383.5 million kuna in sales revenue was generated. This realisation represents growth of 1.6 percent compared to the year before. Higher sales revenues are the result of revenue growth in two important business segments – Food and Pharmaceuticals. The Nutrition segment generated 2,634 million kuna, while Pharmaceuticals recorded 749.5 million kuna in sales revenue, with the largest contribution from the Prescription Medicines category, which increased by 5.4 percent.
The net profit of the Croatian company Podravka for the aforementioned period amounts to 259.3 million kuna and is higher by 23.4 percent when compared to the comparable period from one year before.
It’s worth mentioning that the price of Podravka’s shares on September the 30th this year amounted to 664 kuna, while back on December the 31st, 2020, they amounted to 485 kuna, which is a promising increase of 36.9 percent.
For more, check our our dedicated business section.
